Satriyo Dwi Suryantoro, - and Mochammad Thaha, - and Pranawa, - and Djoko Santoso, - and Nunuk Mardiana, - and Widodo, - and Aditiawardana, - and Artaria Tjempakasari, - and Ardityo Rahmat Ardhany, - and Dana Pramudya, - and Decsa Medika Hertanto, - and Evy Febriane, - and Meryana, - and Maria Angela, - and Ari Christy Muliono, - and Handoko Tanuwidjaja, - and Philia Setiawan, - and David Sugiarto, - (2021) Severe COVID-19 infection in a kidney transplant recipient treated with lopinavir/ritonavir, hydroxychloroquine and dexamethasone. Journal of Infection in Developing Countries, 15 (9). pp. 1257-1262. ISSN 1972-2680

	Text (Artikel) 02. Severe COVID-19 infection in a kidney transplant recipient treated with.pdf Download (1MB)
	Text (Bukti Korespondensi) JIDC - Kidney Transplant.pdf Download (563kB)
	Text (Peer Review) 2.pdf Download (1MB)
	Text (Similarity) Severe COVID-19 infection in a kidney transplant recipient treated with lopinavir_ritonavir, hydroxychloroquine and dexamethasone.pdf Download (2MB)

Abstract

Severe COVID-19 infection management for a recipient of kidney transplant has debatable prognosis and treatment. We described the case of a COVID-19 infected 70 year old female, previously had renal transplantation in 2017. The patient took immunosuppressive agents as routine drugs for transplant recipient status and received lopinavir/ritonavir, hydroxychloroquine, and dexamethasone daily at the hospitalization. Specific question arises about renal transplant recipients being infected by COVID-19 – whether the infection will get worse compared to those without immunosuppresive agent. In this case, author decided to stop the immunosuppressive agent followed administration of combination lopinavir/ritonavir, hydroxychloroquine, and dexamethasone that gives a good clinical impact change to patient’s condition after once getting worsened and mechanically ventilated. Nevertheless, the assessment of risk and benefit in continuing immunosuppressive drugs is concurrently essential due to the prevention of transplant rejection.

Actions (login required)

View Item